Development of Solid Phase Extraction Method Based on Ion Imprinted Polymer for Determination of Cr(III) Ions by ETAAS in Waters

In this work, a new solid phase extraction method for the determination of chromium species in water samples by electrothermal atomic absorption spectrometry was developed. For selective separation of Cr(III) ions under dynamic conditions, two ion imprinted polymers containing Cr(III)-1,10-phenanthroline complex (Cr(III)-phen) were prepared with the use of one (styrene, ST) or two (styrene and 4-vinylpyridine, ST-4VP) functional monomers. The physicochemical properties of those solid sorbents towards Cr(III) ions were studied and compared. It was found that Cr(III) ions were retained on the Cr(III)-phen-ST and Cr(III)-phen-ST-4VP polymers with high efficiency and repeatability (91.6% and 92.9%, RSD < 2%) from solutions at pH 4.5. The quantitative recovery of the analyte (91.7% and 93.9%, RSD < 4%) was obtained with 0.1 mol/L EDTA solution. The introduction of 4VP, an additional functional monomer, improved selectivity of the Cr(III)-phen-ST-4VP polymer towards Cr(III) ions in the presence of Cu(II), Mn(II) and Fe(III) ions, and slightly decreased the sorption capacity and stability of that polymer. The accuracy of procedures based on both polymeric sorbents was proved by analyzing the standard reference material of surface water SRM 1643e. The method using the Cr(III)-phen-ST polymer was applied for determining of Cr(III) ions in tap water and infusion of a green tea.Research work financed by the Ministry of Science and Education as part of a grant for maintaining research potential awarded to the Faculty of Chemistry, University of Bialystok.Laura Trzonkowska: ; [email protected] Leśniewska: : [email protected] Godlewska-Żyłkiewicz: ; [email protected] Trzonkowska - Department of Analytical Chemistry, Faculty of Chemistry, University of BialystokBarbara Leśniewska - Department of Analytical Chemistry, Faculty of Chemistry, University of BialystokBeata Godlewska-Żyłkiewicz - Department of Analytical Chemistry, Faculty of Chemistry, University of BialystokDhal, B.; Thatoi, H.N.; Das, N.N.; Pandey, B.D. Chemical and microchemical remediation of hexavalent chromium from contaminated soil and mining/metallurgical solid waste: A review. J. Hazard. Mater. 2013, 250–251, 272–291.Sawicka, E.; Jurkowska, K.; Piwowar, A. Chromium(III) and chromium(VI) as important players in the induction of gentoxicity—Current view. Ann. Agric. Environ. Med. 2021, 28, 1–10.Metze, D.; Jakubowski, N.; Klockow, D. Speciation of chromium in environment and food. In Handbook of Elemental Speciation II: Species in the Environment, Food, Medicine and Occupational Health; Cornelis, R., Crews, H., Caruso, J., Heumann, K.G., Eds.; John Wiley and Sons, Ltd.: Chichester, UK, 2005; pp. 120–134.Vincent, J.B. New evidence against chromium as an essential trace element. J. Nutr. 2017, 147, 2212–2219.EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies). Scientific opinion on Dietary Reference Values for chromium. EFSA J. 2014, 12, 3845.Staniek, H.; Krejpcio, Z.; Wieczorek, D. The effects of high dietary doses of chromium(III) complex with propionic acid on nutritional and selected blood indices in healthy female rats. Biol. Trace. Elem. Res. 2016, 171, 192–200.Fang, Z.; Zhao, M.; Zhen, H.; Chen, L.; Shi, P.; Huang, Z. Genotoxicity of tri- and hexavalent chromium compounds in vivo and their modes of action on DNA damage in vitro. PLoS ONE 2014, 9, e103194.Kotaś, J.; Stasicka, Z. Chromium occurrence in the environment and methods of its speciation. Environ. Pollut. 2000, 107, 263–283.Kumar, R.A.; Riyazuddin, P. Chromium speciation in a contaminated groundwater: Redox processes and temporal variability. Environ. Monit. Assess. 2011, 176, 647–662.Bakshi, A.; Panigrahi, A.K. A comprehensive review on chromium induced alterations in fresh water fishes. Toxicol. Rep. 2018, 5, 440–447.European Council, Council Directive 98/83/EC of 3 November 1998 on the Quality of Water Intended for Human Consumption. Off. J. 1998, L330, 32–54.Spanu, D.; Monticelli, D.; Binda, G.; Dossi, C.; Rampazzi, L.; Recchia, S. One-minute highly selective Cr(VI) determination at ultra-trace levels: An ICP-MS method based on the on-line trapping of Cr(III). J. Hazard. Mat. 2021, 412, 125280.Wani, A.A.; Khan, A.M.; Manea, Y.K.; Salem, M.A.S.; Shahadat, M. Selective adsorption and ultrafast fluorescent detection of Cr(VI) in wastewater using neodymium doped polyaniline supported layered double hydroxide nanocomposite. J. Hazard. Mat. 2021, 416, 125754.Trzonkowska, L.; Leśniewska, B.; Godlewska-Żyłkiewicz, B. Recent advances in on-line methods based on extraction for speciation ˙analysis of chromium in environmental matrices. Crit. Rev. Anal. Chem. 2015, 17, 305–322.Diniz, K.M.; Teixeira Tarley, C.R. Specition analysis of chromium in water samples through sequential combination of dispersive magnetic solid phase extraction using mesoporous amino-functionalized Fe3O4-SiO2 nanoparticles and cloud point extraction. Microchem. J. 2015, 123, 185–195.Herrero-Latorre, C.; Barciela-García, J.; García-Martín, S.; Pena-Crecente, R.M. Graphene and carbon nanotubes as solid phase extraction sorbents for the speciation of chromium: A review. Anal. Chim. Acta 2018, 1002, 1–17.Mohammadkhani, S.; Gholami, M.R.; Aghaie, M. Thermodynamic study of Cr+3 ions removal by “MnO2/MWCNT” nanocomposite. Orient. J. Chem. 2015, 31, 1429–1436.Rezvani, M.; Asgharinezhad, A.A.; Ebrahimzadeh, H.; Shekari, N. A polyaniline-magnetite nanocomposite as an anion exchange sorbent for solid-phase extraction of chromium(VI) ions. Microchim. Acta 2014, 181, 1887–1895.Karimi, M.A.; Shahin, R.; Mohammadi, S.Z.; Hatefi-Mehrjardi, A.; Hashemi, J.; Yarahmadi, J. Speciation analysis of Cr(III) and Cr(VI) after solid phase extraction using modified magnetite nanoparticles. J. Chin. Chem. Soc. 2013, 60, 1339–1346.Branger, C.; Meouche, W.; Margaillan, A. Recent advances on ion-imprinted polymers. React. Funct. Polym. 2013, 73, 859–875.El Ouardi, Y.; Giove, A.; Laatikainen, M.; Branger, C.; Laatikainen, K. Benefit of ion imprinting technique in solid-phase extraction of heavy metals, special focus on the last decade. J. Environ. Chem. Eng. 2021, 9, 106548.Zambrzycka-Szelewa, E.; Leśniewska, B.; Godlewska-Żyłkiewicz, B. Preparation and application of ion-imprinted polymer ˙sorbents in separation process of trace metals. In MIP Synthesis, Characteristics and Analytical Application; Mar´c, M., Ed.; Comprehensive Analytical Chemistry; Elsevier: Amsterdam, The Netherlands, 2019; Volume 86, pp. 261–293.Birlik, E.; Ersoz, A.; Denizil, A.; Say, R. Cr(III)-imprinted polymeric beads: Sorption and preconcentration studies. J. Hazard. Mater. 2007, 140, 110–116.Leśniewska, B.; Jakubowska, I.; Zambrzycka, E.; Godlewska-Żyłkiewicz, B. A novel ion-imprinted polymeric sorbent for ˙separation and determination of chromium(III) species in wastewater. Turk. J. Chem. 2016, 40, 933–943.Leśniewska, B.; Trzonkowska, L.; Zambrzycka, E.; Godlewska-Żyłkiewicz, B. Multi-commutation flow system with on-line solid ˙phase extraction exploiting the ion-imprinted polymer and FAAS detection for chromium speciation analysis in sewage samples. Anal. Methods 2015, 7, 1517–1526.Leśniewska, B.; Jeglikowska, A.; Godlewska-Żyłkiewicz, B. Chromium speciation in wastewater and sewage by solid-phase ˙ extraction using a new diphenylcarbazone-incorporated resin. Water Air Soil Pollut. 2016, 227, 291.Leśniewska, B.; Godlewska-Żyłkiewicz, B.; Wilczewska, A.Z. Separation and preconcentration of trace amounts of Cr(III) ions on ˙ion imprinted polymer for atomic absorption determinations in surface water and sewage samples. Microchem. J. 2012, 105, 88–93.Izzataddini, A.; Nurani, D.A.; Rahayu, D.U.C.; Abdullah, I. Preparation and characterization of an ion imprinted polymer for selective separation of Cr(III) ions from water. AIP Conf. Proc. 2020, 2242, 040036.An, F.; Gao, B. Adsorption characteristics of Cr(III) ionic imprinting polyamine on silica gel surface. Desalination 2009, 249, 1390–1396.Zhang, N.; Suleiman, J.S.; He, M.; Hu, B. Chromium(III)-imprinted silica gel for speciation analysis of chromium in environmental water samples with ICP-MS detection. Talanta 2008, 75, 536–543.Liu, Y.; Meng, X.; Han, J.; Liu, Z.; Meng, M.; Wang, Y.; Chen, R.; Tian, S. Speciation, adsorption and determination of chromium(III) and chromium(VI) on a mesoporous surface imprinted polymer adsorbent by combining inductively coupled plasma atomic emission spectrometry and UV spectrophotometry. J. Sep. Sci. 2013, 36, 3949–3957.Cen, S.; Li, W.; He, R.; Tan, J.; Wang, H.; Wei, C.; Tang, Y. Preparation of an ion imprinted functionalized mesoporous silica for rapid and specific absorption Cr(III) ions in effluents. RSC Adv. 2017, 7, 37778–37786.Jamshidi, M.; Ghaedi, M.; Dashtian, K.; Hajati, S. New ion-imprinted polymer-functionalized mesoporous SBA-15 for selective separation and preconcentration of Cr(III) ions: Modeling and optimization. RSC Adv. 2015, 5, 105789–105799.Trzonkowska, L.; Leśniewska, B.; Godlewska-Żyłkiewicz, B. Studies on the effect of functional monomer and porogen on the ˙properties of ion imprinted polymer based on Cr(III)-1,10-phenanthroline complex designer for selective removal of Cr(III) ions. React. Funct. Polym. 2017, 117, 131–139.Gao, X. Cis-dichloridobis(1,10-phenanthroline)chromium(III) chloride. Acta Cryst. 2011, E67, m139.Hoet, P. Speciation of chromium in occupational exposure and clinical aspects. In Handbook of Elemental Speciation II: Species in the Environment, Food, Medicine and Occupational Health; Cornelis, R., Crews, H., Caruso, J., Heumann, K.G., Eds.; John Wiley and Sons, Ltd.: Chichester, UK, 2005; pp. 135–157.Inczedy, J.; Lengyel, T.; Ure, A.M.; Gelencser, A.; Hulanicki, A. Compendium of Analytical Nomenclature, 3rd ed.; IUPAC, Blackwell Science: Oxford, UK, 1998.Tiwari, S.; Sharma, N.; Saxena, R. On-line speciation of chromium using a modified chelating resin and determination in industrial water samples by flame atomic absorption spectrometry. New J. Chem. 2016, 40, 1412–1419.Saxena, R.; Sharma, N.; Tiwari, S. Chromium speciation using flow-injection preconcentration on xylenol orange functionalized Amberlite XAD-16 and determination in industrial water samples by flame atomic absorption spectrometry. Anal. Sci. 2015, 31, 1303–1308.Karak, T.; Bhagat, R.M. Trace elements in tea leaves, made tea and tea infusion: A review. Food Res. Int. 2010, 43, 2234–2252.Hamilton, E.M.; Young, S.D.; Bailey, E.H.; Watts, M.J. Chromium speciation in foodstuffs: A review. Food Chem. 2011, 129, 1839–1843.Xiong, W.; Cheng, C.; Yang, Y. Determination of total chromium in tea samples by suspension dispersive solid phase extraction combined with silver nanoparticles and using flame atomic absorption spectrometry. Anal. Methods 2015, 7, 2093–2099.14411

Zastosowanie terapii komórkowych w leczeniu cukrzycy typu 1

Nowadays, an increase in new cases of type 1 diabetes has been observed. Therefore, the researchers and physicians have been working on new drugs that could stop development of type 1 diabetes or cure the existing disease. The results of cellular therapies based on stem cells, regulatory T-cells or pancreatic islets are promising. All procedures improve glycaemic control, and some of them eliminate the need for supply of exogenous insulin for a long term.Współcześnie obserwujemy wyraźny wzrost liczby zachorowań na cukrzycę typu 1. Z tego względu naukowcy oraz lekarze pracują and nowymi terapiami, które pozwoliłyby zatrzymać rozwój lub całkowicie wyleczyć z cukrzycy typu 1. Wyniki terapii komórkowych z zastosowaniem komórek macierzystych, limfocytów T regulatorowych oraz wysp trzustkowych są obiecujące. Wszystkie poprawiają kontrolę glikemii, a niektóre z nich pozwalają na uzyskanie nawet długoterminowej niezależności od egzogennej insuliny

Mast cell derived carboxypeptidase A3 is decreased among patients with advanced coronary artery disease

Background: Coronary artery disease (CAD) affects milions of people and can result in myocardialinfarction (MI). Previously, mast cells (MC) have been extensively investigated in the context of hypersensitivity,however as regulators of the local inflammatory response they can potentially contribute toCAD and/or its progression. The aim of the study was to assess if serum concentration of MC proteases:carboxypeptidase A3, cathepsin G and chymase 1 is associated with the extension of CAD and MI.Methods: The 44 patients with angiographically confirmed CAD (23 subjects with non-ST-segmentelevation MI [NSTEMI] and 21 with stable CAD) were analyzed. Clinical data were obtained as wellserum concentrations of carboxypeptidase A3, cathepsin G and chymase 1 were also measured.Results: Patients with single vessel CAD had higher serum concentration of carboxypeptidase thanthose with more advanced CAD (3838.6 ± 1083.1 pg/mL vs. 2715.6 ± 442.5 pg/mL; p = 0.02). Therewere no significant differences in levels of any protease between patients with stable CAD and those withNSTEMI. Patients with hypertension had ≈2-fold lower serum levels of cathepsin G than normotensiveindividuals (4.6 ± 0.9 pg/mL vs. 9.4 ± 5.8 pg/mL; p = 0.001). Cathepsin G levels were also decreasedin sera of the current smokers as compared with non-smokers (3.1 ± 1.2 ng/mL vs. 5.8 ± 1.2 ng/mL,p = 0.02).Conclusions: Decreased serum level of carboxypeptidase is a hallmark of more advanced CAD. Lowerserum levels of carboxypeptidase A3 and catepsin G are associated with risk factors of blood vessel damagesuggesting a protective role of these enzymes in CAD

Mild hypothermia provides Treg stability

Regulatory T cells (Tregs) play crucial role in maintenance of peripheral tolerance. Recent clinical trials confirmed safety and efficacy of Treg treatment of deleterious immune responses. However, Tregs lose their characteristic phenotype and suppressive potential during expansion ex vivo. Therefore, multiple research teams have been studding Treg biology in aim to improve their stability in vitro. In the current paper, we demonstrate that mild hypothermia of 33 °C induces robust proliferation of Tregs, preserves expression of FoxP3, CD25 and Helios, and prevents TSDR methylation during culture in vitro. Tregs expanded at 33 °C have stronger immunosuppressive potential and remarkably anti-inflammatory phenotype demonstrated by the whole transcriptome sequencing. These observations shed new light on impact of temperature on regulation of immune response. We show that just a simple change in temperature can preserve Treg stability, function and accelerate their proliferation, responding to unanswered question- how to preserve Treg stability in vitro

Treatment of Graft-versus-Host Disease with Naturally Occurring T Regulatory Cells

A significant body of evidence suggests that treatment with naturally occurring CD4(+)CD25(+) T regulatory cells (Tregs) is an appropriate therapy for graft-versus-host disease (GvHD). GvHD is a major complication of bone marrow transplantation in which the transplanted immune system recognizes recipient tissues as a non-self and destroys them. In many cases, this condition significantly deteriorates the quality of life of the affected patients. It is also one of the most important causes of death after bone marrow transplantation. Tregs constitute a population responsible for dominant tolerance to self-tissues in the immune system. These cells prevent autoimmune and allergic reactions and decrease the risk of rejection of allotransplants. For these reasons, Tregs are considered as a cellular drug in GvHD. The results of the first clinical trials with these cells are already available. In this review we present important experimental facts which led to the clinical use of Tregs. We then critically evaluate specific requirements for Treg therapy in GvHD and therapies with Tregs currently under clinical investigation, including our experience and future perspectives on this kind of cellular treatment

Cytokine Imprint in Preeclampsia

The hallmark of preeclampsia (PE) is a shift toward persistent inflammatory response, accompanied by endothelial dysfunction. The driving forces in PE are proinflammatory cytokine and growth factors, in parallel with reduced functionality of anti-inflammatory effectors, like regulatory T cells are observed. Unfortunately, no conclusive mechanism underlying preeclampsia has been identified. For this reason, research on preeclampsia is needed to provide a state of the art understanding of the pathophysiology, identification of new diagnostics tools and the development of targeted therapies. The 68 patients were divided into three groups: gestational hypertension (GH) group (n = 19) and PE group (n = 28) and a control group (n = 21). We have tested a set of 53 cytokines, chemokines and growth factors in preeclampsia and gestational hypertension, and then compared them with normal pregnancies. Using a diagnostic test assessment characteristic parameters (IL-22, MDC/CCL22, IL-2/IL-4 ratio) have been identified and cut-off values have been proposed to diagnose preeclampsia. All parameters had high negative or positive predictive values, above 80%. In conclusion, we have proposed a potential set of immune parameters to diagnose preeclampsia

Beyond FOXP3:a 20-year journey unravelling human regulatory T-cell heterogeneity

The initial idea of a distinct group of T-cells responsible for suppressing immune responses was first postulated half a century ago. However, it is only in the last three decades that we have identified what we now term regulatory T-cells (Tregs), and subsequently elucidated and crystallized our understanding of them. Human Tregs have emerged as essential to immune tolerance and the prevention of autoimmune diseases and are typically contemporaneously characterized by their CD3+CD4+CD25high CD127lowFOXP3+ phenotype. It is important to note that FOXP3+ Tregs exhibit substantial diversity in their origin, phenotypic characteristics, and function. Identifying reliable markers is crucial to the accurate identification, quantification, and assessment of Tregs in health and disease, as well as the enrichment and expansion of viable cells for adoptive cell therapy. In our comprehensive review, we address the contributions of various markers identified in the last two decades since the master transcriptional factor FOXP3 was identified in establishing and enriching purity, lineage stability, tissue homing and suppressive proficiency in CD4+ Tregs. Additionally, our review delves into recent breakthroughs in innovative Treg-based therapies, underscoring the significance of distinct markers in their therapeutic utilization. Understanding Treg subsets holds the key to effectively harnessing human Tregs for immunotherapeutic approaches